About us

Polpharma Biologics is the trusted developer & manufacturer of biosimilars.

We are an international company, with integrated operations in the European Union, passionate about broadening access to biological medicines.

We care about global sustainability, speed to market, scientific rigour - in compliance with the highest quality requirements.

We care that our partners and our people enjoy working with us.

Our history

Our values

These are the values that we at Polpharma Biologics are guided by, help shape our decisions and drive us forward.

We care about creating quality biologics with passion

  • We are passionate about providing safe and effective biosimilars to patients.
  • We work with dedication to find innovative solutions.
  • We anticipate potential issues before they arise, always ensuring high quality & compliant outcomes.

We care about delivering on our commitments

  • We are committed to positive outcomes and delivering projects on time and budget.
  • We manage programs diligently and communicate clearly and concisely.
  • We are self-motivated & proactive to reach the end result.

We care about being respectful and transparent

  • We are open and honest; integrity is in our DNA.
  • We value everyone equally and treat others with respect.
  • We collaborate and rely on each other.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

icon Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

icon Warsaw

Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

icon Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

  • Gdańsk
  • Warsaw - Duchnice
  • Utrecht
  • Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

  • Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

  • Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Innovation in Poland

Over the last decade Polpharma Biologics has created a biotechnology sector almost from scratch in Poland. We consistently invest, not only laboratories and production lines, but also in know-how, driving growth of highly-qualified jobs, as well as developing cooperation between science and business.

Industry leading team

At Polpharma Biologics, our commitment to excellence begins at the top. With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals. Our international management team brings both knowledge and passion to every project.

Learn more

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.